EUVIMEDEUVIMED entdecken
ValidierungsstudieMultizentrische Studie

Validation of Drum Tower Severity Scoring ( DTSS ) System for Pyrrolizidine Alkaloid‐Induced Hepatic Sinusoidal Obstruction Syndrome

Li Li Zhang, Feng Zhang, Kai Wang, Yu Hu Song iD, Ying Zhang, Zhen Yu Zhou, Wei Jie Dai, Lei Wang iD, Huan Chen, Qin Yin, Yu Zheng Zhuge, Wei Zhang iD

Journal of Digestive Diseases · 2025-03 · 26 (3-4) · 150-157

DOI: 10.1111/1751-2980.13347 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Digestive Diseases, online erschienen am 06.05.2025. Verfasst von Li Li Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, Jiangsu Province, China. Hauptthemen laut MEDLINE: Hepatic Veno-Occlusive Disease, Severity of Illness Index, Pyrrolizidine Alkaloids, Anticoagulants. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: General Program of Wuxi Municipal Health and Family Planning Commission, Wuxi Health and Family Planning Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The Drum Tower Severity Scoring (DTSS) system is a novel tool designed for assessing the outcome of anticoagulation therapy and disease severity in patients with pyrrolizidine alkaloid‐induced hepatic sinusoidal obstruction syndrome (PA‐HSOS). The aim of this study was to validate the predictive performance of the DTSS system in PA‐HSOS patient outcome.

Methods

We conducted a retrospective analysis of 111 PA‐HSOS patients who received standard anticoagulation–transjugular intrahepatic portosystemic shunt (TIPS) stepwise therapy from six hospitals in China. Patients were categorized into two groups based on whether they responded to anticoagulation therapy. The predictive performance of the DTSS system was evaluated through the efficacy of anticoagulation therapy, the area under the receiver operating characteristic curve (AUROC), calibration curve, decision curve analysis (DCA), and clinical impact curve (CIC) analysis.

Results

The response rates to anticoagulation therapy varied among patients with DTSS of different severity, being 94.12% for mild, 57.81% for moderate, and 13.33% for severe cases. The DTSS system demonstrated a robust predictive performance, with an AUROC of 0.864. The calibration curve indicated a close match between the predicted and observed effects of the DTSS system. Good calibration was confirmed by the Hosmer–Lemeshow test ( p = 0.704), and both the DCA and CIC analysis indicated high clinical utility of the DTSS system.

Conclusion

The DTSS system is a practical tool that uses easily accessible data to predict the initial response to anticoagulation therapy in PA‐HSOS patients, showing robust predictive performance and significant clinical benefit in guiding personalized management strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Veno-Occlusive DiseaseSeverity of Illness IndexPyrrolizidine AlkaloidsAnticoagulantsHumansMaleRetrospective StudiesFemaleMiddle AgedAgedAdultPortasystemic Shunt, Transjugular IntrahepaticROC CurvePredictive Value of Tests

Stichwörter der Autor:innen

Drum Tower Severity Scoring systemanticoagulationchemical‐ and drug‐induced liver injurypyrrolizidine alkaloid‐induced hepatic sinusoidal obstruction syndrometransjugular intrahepatic portosystemic shunt

Substanzen

Pyrrolizidine AlkaloidsAnticoagulants

Autor:innen und Institutionen

  • Department of Gastroenterology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, Jiangsu Province, China.
  • Department of Gastroenterology, Jiangnan University Medical Center, Wuxi No. 2 People's Hospital, Wuxi, Jiangsu Province, China.
  • Department of General Surgery, Xuzhou Medical University Affiliated Hospital, Xuzhou, Jiangsu Province, China.
  • Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
  • Department of Infectious Disease, Nantong Third People's Hospital, Nantong, Jiangsu Province, China.
  • Department of Gastroenterology, Yixing People's Hospital, Yixing, Jiangsu Province, China.

ORCID-Profile: Yu Hu Song, Lei Wang, Wei Zhang

Förderung

  • General Program of Wuxi Municipal Health and Family Planning Commission
  • Wuxi Health and Family Planning Commission

Zitieren

APA

Zhang, L. L., Zhang, F., Wang, K., Song, Y. H., Zhang, Y., Zhou, Z. Y., Dai, W. J., Wang, L., Chen, H., Yin, Q., Zhuge, Y. Z., & Zhang, W. (2025). Validation of Drum Tower Severity Scoring ( DTSS ) System for Pyrrolizidine Alkaloid‐Induced Hepatic Sinusoidal Obstruction Syndrome. Journal of Digestive Diseases, 26(3-4), 150-157. https://doi.org/10.1111/1751-2980.13347

Vancouver

Zhang LL, Zhang F, Wang K, Song YH, Zhang Y, Zhou ZY, et al. Validation of Drum Tower Severity Scoring ( DTSS ) System for Pyrrolizidine Alkaloid‐Induced Hepatic Sinusoidal Obstruction Syndrome. Journal of Digestive Diseases. 2025;26(3-4):150-157. doi:10.1111/1751-2980.13347

BibTeX
@article{Zhang2025,
  author = {Zhang, Li Li and Zhang, Feng and Wang, Kai and Song, Yu Hu and Zhang, Ying and Zhou, Zhen Yu and Dai, Wei Jie and Wang, Lei and Chen, Huan and Yin, Qin and Zhuge, Yu Zheng and Zhang, Wei},
  title = {Validation of Drum Tower Severity Scoring ( DTSS ) System for Pyrrolizidine Alkaloid‐Induced Hepatic Sinusoidal Obstruction Syndrome},
  journal = {Journal of Digestive Diseases},
  year = {2025},
  volume = {26},
  number = {3-4},
  pages = {150--157},
  doi = {10.1111/1751-2980.13347}
}
Kostenlos starten →